US › Healthcare

EDAP TMS SA (EDAP)

US · Healthcare · Medical Distribution

$5.43-0.18%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$17.9M
Revenue YoY
+31.9%
Net profit
$-9.1M
Profit YoY
-28.9%
EPS
$-0.24
EPS estimate
$-0.21
Net margin
-51.0%

EPS came in at -0.24 against a street estimate of -0.21 — a miss of 14.3%.

Key statistics

Market cap
$161.9M
Forward P/E
38.9
P/B
22.75
Book value
$0.52
EPS (TTM)
$-0.82
52-week high
$5.51
52-week low
$1.21
50-day MA
$3.82
200-day MA
$3.30
Beta
-0.10

Analyst view

Analysts rate EDAP TMS SA a hold (1 buy, 2 hold, 0 sell out of 3) with an average price target of $5.83.

Shareholding

Insiders
6.13%
Institutions
38.87%

Largest institutional holders

FundStake
Soleus Capital Management, L.P.19.50%
Morgan Stanley - Brokerage Accounts8.93%
Rock Springs Capital Management LP3.68%
FLAX POND CAPITAL, LLC2.09%
Bruce & Co Inc1.17%
UBS Group AG0.45%
Parkman Healthcare Partners LLC0.41%
OHE Financial Inc0.36%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for EDAP TMS SA — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.